Clinical trials heavily rely on routine testing. Cerba Research's broad portfolio offers a wide range of evaluations in hematology, biochemistry, serology, and urinalysis.
They are the first four assays launched for the Cobas 5800 platform and Roche is pursuing CE marking for other tests, including the Cobas SARS-CoV-2 test.